Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
BioLineRx Ltd. (BLRX) had Gross Margin of 67.99% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$28.94M |
|
$-9.22M |
|
$9.26M |
|
$19.68M |
|
$49.35M |
|
$-20.41M |
|
$11.19M |
|
$-9.22M |
|
$-9.22M |
|
$-9.22M |
|
$-9.22M |
|
$-9.22M |
|
$-9.22M |
|
$-20.41M |
|
$-16.34M |
|
2.00M |
|
2.00M |
|
$-6.00 |
|
$-6.00 |
|
| Balance Sheet Financials | |
$27.10M |
|
$0.39M |
|
$11.80M |
|
$38.91M |
|
$15.41M |
|
$8.96M |
|
$10.04M |
|
$25.45M |
|
$13.46M |
|
$3.01M |
|
$13.46M |
|
2.23M |
|
| Cash Flow Statement Financials | |
$-43.87M |
|
$29.37M |
|
$20.66M |
|
$4.25M |
|
$10.44M |
|
$6.18M |
|
$1.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.76 |
|
-- |
|
-- |
|
0.40 |
|
1.00 |
|
|
Gross Margin |
67.99% |
-70.52% |
|
-70.52% |
|
-56.47% |
|
-31.86% |
|
-31.86% |
|
$-43.93M |
|
-- |
|
-- |
|
-- |
|
0.74 |
|
2.95 |
|
7.32 |
|
49.87 |
|
-68.50% |
|
-306.14% |
|
-23.70% |
|
-41.13% |
|
$6.04 |
|
$-22.00 |
|
$-21.97 |
|